Biotech in the spotlight: Century Therapeutics says its iPSC-derived islet replacement therapy CNTY-813 is on track for an FDA IND submission in 4Q 2026, after ADA 2026 preclinical results showed durable glucose control and immune evasion; the company also reaffirmed progress on its CD19 CAR-iT program CNTY-308 and reported a Q2 2026 cash runway into 1Q 2029. Local health leadership: Madrigal Pharmaceuticals added J&J R&D executive John C. Reed, M.D., Ph.D., to its board as it pushes forward its MASH work. Pennsylvania quantum push: State lawmakers heard that Pennsylvania’s Keystone AI + Quantum Factory—linking Penn, Pitt, Carnegie Mellon, Drexel, Penn State, Temple, and Lehigh—aims to build a statewide quantum ecosystem to compete for federal and industry dollars. Education tech debate: Pennsylvania and New Jersey moved to protect kids online as Pennsylvania sues TikTok over safeguards and New Jersey signs new social media rules for minors. Classroom tech reality check: Pennsylvania districts are tightening cellphone policies, while other coverage highlights how schools are spending big on AI but still struggle to decide what’s actually worth it. Energy + storage research: A vanadium flow battery study is underway with Alcoa to assess long-duration storage for refinery operations. Community impacts of tech: Data center concerns keep rising, with residents organizing around zoning hearings and infrastructure strain.